How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.


Par Pharmaceuticals is seeking partnerships in late stage generics and branded products in CNS, CV, inflammatory, infectious and gastro-intestinal diseases

Organization name

Par Pharmaceutical business development


Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets.

Par's generic drug portfolio includes central nervous system, cardiovascular, anti-inflammatory, gastrointestinal, and anti-infective therapeutics.

Par's strategic partnerships are an integral component of the Company's growth strategy. They continue to build and foster strategic business alliances with major pharmaceutical companies, specialist drug delivery companies and other product and service providers.

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.


latest entries